They may recommend staying at your current dose longer, temporarily reducing your dose, or providing additional strategies to manage side effects
Small molecules, in a way, are more tried and tested traditionally, right
In short, the easier your app makes it to stay consistent, the better your odds of success
SeekPeptides members frequently navigate this exact decision, and the answer almost always depends on individual circumstances rather than blanket recommendations
Retatrutide (LY3437943) simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from approved dual or single agonists such as tirzepatide and semaglutide
Not legally in North or South Carolina